Emerging and future therapies for nonalcoholic steatohepatitis in adults.
Title | Emerging and future therapies for nonalcoholic steatohepatitis in adults. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Mintziori, G., & Polyzos S. A. |
Journal | Expert Opin Pharmacother |
Volume | 17 |
Issue | 14 |
Pagination | 1937-46 |
Date Published | 2016 Oct |
ISSN | 1744-7666 |
Keywords | Adult, Chenodeoxycholic Acid, Drug Design, Glucagon-Like Peptide 1, Humans, Non-alcoholic Fatty Liver Disease, Peroxisome Proliferator-Activated Receptors, Thiazolidinediones, Vitamin E |
Abstract | INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is a disease of increasing prevalence with morbidity and mortality closely related to cardiovascular disease, malignancies and cirrhosis. Despite the need for pharmacological treatment and intense research in the field, there is currently no approved agent for NASH. |
DOI | 10.1080/14656566.2016.1225727 |
Alternate Journal | Expert Opin Pharmacother |
PubMed ID | 27564402 |